Cell Rep.Accept in principle).
2. Wang X*, Wang Y*, Fang Z*, Wang H, Zhang J, Zhang L, Huang H, Jiang Z, Jin Y, Han X, Hou S, Zhou B, Meng F, Chen L, Wong K, Liu J, Zhang Z, Zhang Z, Chen H, Sun Y, Ji H.Synthetic lethality by targeting HSPA1A in ARID2-deficient lung cancer. National Science Review. 2021.
3. Wang Y*, Zhang J, Ren S, Sun D, Huang HY, Wang H, Jin Y, Li F, Zheng C, Yang L, Deng L, Jiang Z, Jiang T, Han X, Hou S, Guo C, Li F, Gao D, Qin J, Gao D, Chen L, Lin SH, Wong KK, Li C, Zhou C, Ji H. Drug tolerance and resistance regulated by epigenetic memory through branched-chain amino acid metabolic reprogramming. Cell Rep.2019.
4. Wang Y*, Cao J*, Liu W*, Zhang J, Wang Z, Zhang Y, Hou L, Chen S, Hao P, Zhang L, Zhuang M, Yu Y, Li D, Fan G. Protein tyrosine phosphatase receptor type R (PTPRR) antagonizes the Wnt signaling pathway in ovarian cancer by dephosphorylating and inactivating β-catenin.J Biol Chem. 2019.
5. Zheng C*, Wang Y*, Yang L, Zhou S, Gao Y, Li F, Feng Y, Wang Z, Zhan L, Yan Q, Zhu X, Wong KK, Chen Z, Ji H. Cell Division Cycle 42 plays a Cell type-Specific role in Lung Tumorigenesis.Sci Rep. 2017.
6. Liu X*, Wang Y*, Ji H, Aihara K, Chen L. Personalized characterization of diseases using sample-specific networks. Nucleic Acids Research. 2016.